FFIV
67
3
KMI
73
4
MAR
60
3
LMT
44
5
KLAC
59
3
STX
37
2
AXP
67
4
MS
70
6
EQT
48
6
CMCSA
52
3
PEG
57
2
MNST
52
6
AMZN
63
5
WU
16
4
INTC
40
3
EA
44
3
FTI
63
2
ZBH
71
3
CNX
71
3
FLS
63
2
FFIV
67
3
KMI
73
4
MAR
60
3
LMT
44
5
KLAC
59
3
STX
37
2
AXP
67
4
MS
70
6
EQT
48
6
CMCSA
52
3
PEG
57
2
MNST
52
6
AMZN
63
5
WU
16
4
INTC
40
3
EA
44
3
FTI
63
2
ZBH
71
3
CNX
71
3
FLS
63
2
Financhill
Back

iShares US Pharmaceuticals ETF Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30

IHE
iShares US Pharmaceuticals ETF

Last Price:
$66.56
Seasonality Move:
1.02%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

iShares US Pharmaceuticals ETF Stock Forecast

  • Over the next 52 weeks, iShares US Pharmaceuticals ETF has on average historically risen by 8.5% based on the past 18 years of stock performance.
  • iShares US Pharmaceuticals ETF has risen higher in 13 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.22%
  • Is iShares US Pharmaceuticals ETF Stock Undervalued?
    The current iShares US Pharmaceuticals ETF [IHE] share price is $66.56. The Score for IHE is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • IHE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will iShares US Pharmaceuticals ETF Stock Go Up Next Year?

  • Over the next 52 weeks, iShares US Pharmaceuticals ETF has on average historically risen by 8.5% based on the past 18 years of stock performance.

iShares US Pharmaceuticals ETF Stock Rating

Sell
30
iShares US Pharmaceuticals ETF (IHE) is a Sell

Is iShares US Pharmaceuticals ETF overpriced?

  • iShares US Pharmaceuticals ETF has risen higher in 13 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.22%

iShares US Pharmaceuticals ETF Stock Price History

Is IHE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IHE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
72.94
52-Week Low:
60.88

Prediction Charts

Market Cap:
0
Price in USD:
66.56
Volume:
167.1K
Beta:
0.70

Technical Analysis

SMA50:
68.80
SMA100:
69.71
SMA200:
68.01
52-Wk Change:
9.16%

Stock Predictions

  • Is iShares US Pharmaceuticals ETF stock public?
    Yes, iShares US Pharmaceuticals ETF is a publicly traded company.
  • What is the iShares US Pharmaceuticals ETF stock quote today?
    The iShares US Pharmaceuticals ETF stock price is 66.56 USD today.
  • How to buy iShares US Pharmaceuticals ETF stock online?
    You can buy iShares US Pharmaceuticals ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-4 68.99 69.05 69.47 68.83
Dec-5 69.00 68.80 69.00 68.68
Dec-6 69.08 68.96 69.17 68.85
Dec-9 68.79 68.49 68.92 68.48
Dec-10 67.99 67.95 68.60 67.88
Dec-11 67.43 67.54 67.82 67.14
Dec-12 67.73 67.11 67.78 67.06
Dec-13 66.98 66.92 67.08 66.64
Dec-16 67.31 66.58 67.49 66.44
Dec-17 66.78 66.83 66.96 66.35
Dec-18 66.92 65.59 66.92 65.58
Dec-19 65.37 65.15 65.78 64.99
Dec-20 65.93 65.71 66.47 65.58
Dec-24 66.34 66.56 66.57 65.99

iShares US Pharmaceuticals ETF Earnings

Data Unavailable

iShares US Pharmaceuticals ETF Forecast Revenue Growth

Data Unavailable

* iShares US Pharmaceuticals ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.